Starling Oncology highlights leadership participation at Deutsche Bank 2026 Healthcare Summit

• Starling Oncology leadership highlighted recent participation in major value-based oncology conferences, citing its Starling Nexus utilization management platform.
• Chief Clinical Officer Jeffrey Langsam joined a “Future of Oncology” panel at Deutsche Bank’s 2026 Healthcare Summit on Sept. 17.
• Chief Medical Officer Yale D. Podnos spoke at the PCOC conference on Sept. 25 on scaling delivery of novel therapies.
• Podnos is scheduled to appear at the AVBCC 2026 Summit in New York on Oct. 8, including a panel on clinical trial access.
• Podnos is also set to present at the APG Fall Conference on Nov. 19 on embedding behavioral health in community oncology.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Starling Oncology Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610011614PRIMZONEFULLFEED9838238) on October 01, 2026, and is solely responsible for the information contained therein.